Overview

Pre- Versus Post-incisional Pregabalin for Postoperative Pain Attenuation and Analgesics Spare in Orthopedic Oncologic Patients

Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
0
Participant gender:
All
Summary
Hypothesis No studies considered the comparison of preemptive vs. post-surgery Pregabalin (PGL) only administration. The investigators believe that the administration of PGL preemptively would diminish pain sensation and therefore the need for opioids administration in orthopedic-oncologic patients more effectively than if administered starting postoperatively.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Treatments:
Analgesics
Pregabalin
Criteria
Inclusion Criteria:

- ASA physical status I-III patients who will undergo bone with or without soft tissue
cancer surgery type II and III [24,25] under general or epidural anesthesia in
Tel-aviv Sourasky Medical Center will be enrolled to this study that will be approved
by our institutional human research and ethics committee.

- All participants will sign a Helsinki-approved informed consent, and will be given
full explanation of the drug, PCA and the numerical rating scale (NRS) during the
pre-anesthesia interview.

Exclusion Criteria:

- These will include allergy to opioids, bupivacaine, midazolam, PGL, or non-steroidal
anti-inflammatory drugs (NSAIDs), a history of chronic pain or psychiatric disorders
and the use of centrally acting drugs of any sort. Patients <18 or >80 years, soldiers
and pregnant women will also be excluded from the study.